Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes

References

• AhujaNLiQMohanALAging and DNA methylation in colorectal mucosa and cancerCancer Res1998585489949850084
   PubMed Web of Science ®Google Scholar
• AmanullahAHoffmanBLiebermannDADeregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A)Blood2000964758210887108
   PubMed Web of Science ®Google Scholar
• AntequeraFBoyesJBirdAHigh levels of de novo methylation and altered chromatin structure at CpG islands in cell linesCell199062503141974172
   PubMed Web of Science ®Google Scholar
• AulCGermingUGattermannNIncreasing incidence of myelodysplastic syndromes: real or fictitious?Leuk Res199822931009585086
   PubMed Web of Science ®Google Scholar
• BennettJMCatovskyDDanielMTProposals for the classification of the myelodysplastic syndromesBr J Haematol198251189996952920
   PubMed Web of Science ®Google Scholar
• BhagwatASRobertsRJGenetic analysis of the 5-azacytidine sensitivity of Escherichia coli K-12J Bacteriol19871691537462435706
   PubMed Web of Science ®Google Scholar
• BirdADNA methylation patterns and epigenetic memoryGenes Dev20021662111782440
   PubMed Web of Science ®Google Scholar
• BirdAPTaggartMHSmithBAMethylated and unmethylated DNA compartments in the sea urchin genomeCell197917889901487434
   PubMed Web of Science ®Google Scholar
• CameronEEBachmanKEMyohanenSSynergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerNat Genet19992110379916800
   PubMed Web of Science ®Google Scholar
• ChesonBDBennettJMKantarjianHReport of an international working group to standardize response criteria for myelodysplastic syndromesBlood2000963671411090046
   PubMed Web of Science ®Google Scholar
• ChristiansenDHAndersenMKPedersen-BjergaardJMethylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaLeukemia20031718131912970781
   PubMed Web of Science ®Google Scholar
• ChristmanJK5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapyOncogene20022154839512154409
   PubMed Web of Science ®Google Scholar
• CornPGSmithBDRuckdeschelESE-cadherin expression is silenced by 5' CpG island methylation in acute leukemiaClin Cancer Res200064243811106238
   PubMed Web of Science ®Google Scholar
• CreusotFAcsGChristmanJKInhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidineJ Biol Chem1982257204186173384
   PubMed Web of Science ®Google Scholar
• DaoMATaylorNNoltaJAReduction in levels of the cyclindependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cellsProc Natl Acad Sci U S A19989513006119789031
   PubMed Web of Science ®Google Scholar
• DelgadoSGomezMBirdAInitiation of DNA replication at CpG islands in mammalian chromosomesEmbo J1998172426359545253
   PubMed Web of Science ®Google Scholar
• DhodapkarMGrillJLustJAAbnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromesLeuk Res199519719267500648
   PubMed Web of Science ®Google Scholar
• DrexlerHGReview of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cellsLeukemia199812845599639410
   PubMed Web of Science ®Google Scholar
• EstellerMCornPGBaylinSBA gene hypermethylation profile of human cancerCancer Res2001613225911309270
   PubMed Web of Science ®Google Scholar
• FrommerMMcDonaldLEMillarDSA genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strandsProc Natl Acad Sci U S A1992891827311542678
   PubMed Web of Science ®Google Scholar
• GarciaMJMartinez-DelgadoBCebrianADifferent incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin’s and CD30-Positive non-Hodgkin’s lymphomasAm J Pathol200216110071312213729
   PubMed Web of Science ®Google Scholar
• Gardiner-GardenMFrommerMCpG islands in vertebrate genomesJ Mol Biol1987196261823656447
   PubMed Web of Science ®Google Scholar
• GermingUGattermannNStruppCValidation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsLeuk Res2000249839211077111
   PubMed Web of Science ®Google Scholar
• GloverABLeyland-JonesBRChunHGAzacitidine: 10 years laterCancer Treat Rep198771737462440570
   PubMedGoogle Scholar
• GoreSDCombination therapy with DNA methyltransferase inhibitors in hematologic malignanciesNat Clin Pract Oncol20052Suppl 1S30516341238
   PubMedGoogle Scholar
• GoreSDBaylinSBDausesTChanges in promoter methylation and gene expression in patients with MDS and MDS-AML treated with 5-Azacitidine and sodium phenylbutyrate [abstract]Blood200410411469
   Web of Science ®Google Scholar
• GreenbergPCoxCLeBeauMMInternational scoring system for evaluating prognosis in myelodysplastic syndromesBlood1997892079889058730
   PubMed Web of Science ®Google Scholar
• GrynJZeiglerZRShadduckRKTreatment of myelodysplastic syndromes with 5-azacytidineLeuk Res200226893712163049
   PubMed Web of Science ®Google Scholar
• HaafTThe effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processesPharmacol Ther19956519467536332
   PubMed Web of Science ®Google Scholar
• HeaneyMLGoldeDWMyelodysplasiaN Engl J Med199934016496010341278
   PubMed Web of Science ®Google Scholar
• HermanJGLatifFWengYSilencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinomaPNAS199491970047937876
   PubMed Web of Science ®Google Scholar
• HoAYPagliucaAKenyonMReduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioningBlood200410416162315059843
   PubMed Web of Science ®Google Scholar
• IssaJPGarcia-ManeroGGilesFJPhase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignanciesBlood200410316354014604977
   PubMed Web of Science ®Google Scholar
• JaenischRBirdAEpigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signalsNat Genet200333Suppl2455412610534
   PubMed Web of Science ®Google Scholar
• JohanMFGoodeveACBowenDTPromoter methylation of RASSFIA, SHP1 and SOCS1 genes in acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) [abstract]Blood20041042999
   Web of Science ®Google Scholar
• JohnARajKMuftiGJLymphocytes but not CD34+ or CD33+ myeloid cells, of MDS have a hypermethylated CDKN2B promoterBr J Haematol2005129Suppl 16
   Google Scholar
• JonesPATaylorSMHemimethylated duplex DNAs prepared from 5-azacytidine-treated cellsNucleic Acids Res198192933476169003
   PubMed Web of Science ®Google Scholar
• JonesPATaylorSMWilsonVLInhibition of DNA methylation by 5-azacytidineRecent Results Cancer Res198384202116189159
   PubMedGoogle Scholar
• JonesPLVeenstraGJWadePAMethylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionNat Genet199819187919620779
   PubMed Web of Science ®Google Scholar
• KaminskasEFarrellATWangYCFDA drug approval summary: Azacitidine (5-azacytidine, VidazaTM) for injectable suspensionOncologist2005101768215793220
   PubMed Web of Science ®Google Scholar
• KornblithABHerndonJE2ndSilvermanLRImpact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B studyJ Clin Oncol20022024415212011121
   PubMed Web of Science ®Google Scholar
• LiQKopeckyKJMohanAEstrogen receptor methylation is associated with improved survival in adult acute myeloid leukemiaClin Cancer Res1999510778410353741
   PubMed Web of Science ®Google Scholar
• LubbertMWijermansPKunzmannRCytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineBr J Haematol20011143495711529854
   PubMed Web of Science ®Google Scholar
• MelkiJRVincentPCClarkSJConcurrent DNA hypermethylation of multiple genes in acute myeloid leukemiaCancer Res19995937304010446989
   PubMed Web of Science ®Google Scholar
• MizunoSChijiwaTOkamuraTExpression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemiaBlood2001971172911222358
   PubMed Web of Science ®Google Scholar
• MuftiGListAFGoreSDMyelodysplastic syndromeHematology200320031769914633782
   PubMedGoogle Scholar
• MundCHackansonBStresemannCCharacterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndromeCancer Res20056570869016103056
   PubMed Web of Science ®Google Scholar
• NajfeldVScaliseAOdchimer-ReissigRThe modulating effect of Azacitidine (Aza C) on the cytogenetically tracked MDS clone impact survival [abstract]Blood20041041429
   Web of Science ®Google Scholar
• NajfeldVSilvermanLRScaliseAModulation of the cytogenetically abnormal myelodysplastic (MDS) clone by Azacitidine (Aza C) [abstract]Blood200210097a
   Web of Science ®Google Scholar
• NakamakiTBartramCSeriuTMolecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromesLeuk Res199721235409111168
   PubMed Web of Science ®Google Scholar
• OkanoMBellDWHaberDADNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian developmentCell1999992475710555141
   PubMed Web of Science ®Google Scholar
• ParkerJEMuftiGJRasoolFThe role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDSBlood2000963932811090080
   PubMed Web of Science ®Google Scholar
• QuesnelBGuillermGVereecqueRMethylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progressionBlood1998912985909531610
   PubMed Web of Science ®Google Scholar
• RajKJohnAHoA5-Azacytidine in the treatment of high risk myelodysplastic syndromes: clinical response can occur without demethylation of the CDKN2B, CDKN1A or TP73 gene promoters [abstract]Blood20041042369
   Web of Science ®Google Scholar
• RajKKJohnAMHoAEarly and sustained response to azacytidine in high-risk MDS patients with monosomy 7 correlates with increased apoptosis and not CDKN2B demethylation [abstract]Blood2005106253015933056
   PubMed Web of Science ®Google Scholar
• RudekMAZhaoMHePPharmacokinetics of 5-Azacitidine given with phenylbutyrate in patients with refractory solid tumors or hematologic malignanciesJ Clin Oncol20052339061115851763
   PubMed Web of Science ®Google Scholar
• RushLJDaiZSmiragliaDJNovel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 lociBlood20019732263311342453
   PubMed Web of Science ®Google Scholar
• SilvermanLRDemakosEPPetersonBLRandomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group BJ Clin Oncol20022024294012011120
   PubMed Web of Science ®Google Scholar
• TeofiliLMartiniMDi MarioAExpression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitorsBlood200198495711435325
   PubMed Web of Science ®Google Scholar
• TeofiliLMorosettiRMartiniMExpression of cyclindependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiationExp Hematol2000285192610812241
   PubMed Web of Science ®Google Scholar
• TessemaMLangerFDingemannJAberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML)Leukemia2003179101812750705
   PubMed Web of Science ®Google Scholar
• TienHFTangJHTsayWMethylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformationBr J Haematol20011121485411167795
   PubMed Web of Science ®Google Scholar
• ToyotaMKopeckyKJToyotaMOMethylation profiling in acute myeloid leukemiaBlood2001972823911313277
   PubMed Web of Science ®Google Scholar
• UchidaTKinoshitaTHottaTHigh-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B geneLeuk Lymphoma19983291810036997
   PubMed Web of Science ®Google Scholar
• van den BoschJLubbertMVerhoefGThe effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromesLeuk Res2004287859015203276
   PubMed Web of Science ®Google Scholar
• VardimanJWThe World Health Organisation (WHO) classification of the myeloid neoplasmsBlood2002100229230212239137
   PubMed Web of Science ®Google Scholar
• WheelerJMEpigenetics, mismatch repair genes and colorectal cancerAnn R Coll Surg Engl200587152015720901
   PubMed Web of Science ®Google Scholar
• WijermansPLubbertMVerhoefGLow-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patientsJ Clin Oncol2000189566210694544
   PubMed Web of Science ®Google Scholar
• WijermansPWLubbertMVerhoefGAn epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patientsAnn Hematol200584Suppl 1391716211386
   PubMed Web of Science ®Google Scholar